Back to top
more

TRUBRIDGE INC (TBRG)

(Delayed Data from NSDQ)

$18.91 USD

18.91
338,378

-2.28 (-10.76%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $18.93 +0.02 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (87 out of 244)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

New Strong Buy Stocks for May 13th

by Zacks Equity Research

IIIN, BMBL, EQX, PAAS and TBRG have been added to the Zacks Rank #1 (Strong Buy) List on May 13, 2025.

Zacks Equity Research

TruBridge (TBRG) Lags Q1 Earnings Estimates

by Zacks Equity Research

TruBridge (TBRG) delivered earnings and revenue surprises of -2.70% and 1.51%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Do Options Traders Know Something About TruBridge Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to TruBridge stock based on the movements in the options market lately.

Zacks Equity Research

Schrodinger (SDGR) Moves 27.4% Higher: Will This Strength Last?

by Zacks Equity Research

Schrodinger (SDGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Zacks Equity Research

Senseonics Holdings (SENS) Reports Q4 Loss

by Zacks Equity Research

Senseonics (SENS) delivered earnings and revenue surprises of 33.33% and 0%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Fulgent Genetics, Inc. (FLGT) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 133.33% and 1.90%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Health Catalyst (HCAT) delivered earnings and revenue surprises of -63.64% and 0.28%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

TruBridge (TBRG) Soars 6.4%: Is Further Upside Left in the Stock?

by Zacks Equity Research

TruBridge (TBRG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

Is the Options Market Predicting a Spike in TruBridge (TBRG) Stock?

by Zacks Equity Research

Investors need to pay close attention to TruBridge (TBRG) stock based on the movements in the options market lately.

Zacks Equity Research

TruBridge (TBRG) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

TruBridge (TBRG) delivered earnings and revenue surprises of -140.38% and 1.86%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Outset Medical (OM) delivered earnings and revenue surprises of 7.14% and 6.22%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Enovis (ENOV) Q2 Earnings Top Estimates

by Zacks Equity Research

Enovis (ENOV) delivered earnings and revenue surprises of 3.33% and 0.70%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

TruBridge (TBRG) Q1 Earnings Miss Estimates

by Zacks Equity Research

TruBridge (TBRG) delivered earnings and revenue surprises of -13.64% and 1.10%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?